Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

NNNN

Anbio Biotechnology

CIK 0001982708 · Nasdaq

NasdaqHealth CareIn Vitro & In Vivo Diagnostic Substances
$11.15
↓ 0.34 (-2.96%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BearishOverall score · based on 2/4 lenses
FundamentalsOwnershipTechnicalsOptions

Risks: Technicals; Excluded: Ownership, Options (no data)

Key stats

Market Cap
$489.39M
P/E Ratio
76.43
EPS
0.15
Dividend Yield
Not covered
52W Position
1%
Beta
0.60

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
16.23
P/S
56.60
EV/Revenue
55.70
ROE
21.2%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 1%
$10.50$55.65

Latest Financials

2025-12-31 FY
Revenue
$8.65M
Net Income
$6.40M
Total Assets
$30.24M
Free Cash Flow
–

Recent news